The malignancy rates in the BI-RADS 3 group substantially exceeded those of women downgraded to BI-RADS 1 or 2 at each follow-up, further supporting short-interval follow-up imaging surveillance.

Data showed that integrating SoftVue with screening mammography significantly improved cancer detection in women with dense breasts.

Multicenter trial finds BI-RADS 3 breast lesions have low cancer rate Date: August 20, 2013 Source: Radiological Society of North America Summary: Based on data from a multi-site imaging trial ...

BI-RADS is an acronym for Breast Imaging-Reporting And Data System developed by the American College of Radiology (ACR), a quality assurance tool originally designed for use with mammography.

Approval was based on data from a published prospective study of 216 women who had BI-RADS 3, 4, or 5 findings on mammography. The Food and Drug Administration (FDA) has expanded the approval of ...

Created with ♥ by RumbleThe mammography report will describe the breast tissue type andother findings using a standardised system for reporting images ofthe breasts, BI-RADS. (Photo: Pexels) ...

Your BI-RADS score provides results from a mammogram screening. Learn reasons you need a mammogram and what the results mean.

Tomosynthesis not only improved the cancer detection rate in women with dense breasts, it also helped increase detection for women in the "fatty breast" BI-RADS categories.

Circumscribed mass at baseline screening mammography in a 40-year-old woman due to a fibroadenoma. (a) Craniocaudal tomosynthesis image shows a circumscribed mass (arrow), which was also evident ...

Based on data from a multi-site imaging trial involving more than 2,600 women, researchers say breast lesions categorized as 'probably benign' on supplemental screening ultrasound could be re ...

Of the 745 BI-RADS 3 lesions, six were malignant for a total malignancy rate of 0.8 percent. The average size of the detected cancers among the BI-RADS 3 lesions was 10 millimeters.

Specifically, the combination increased sensitivity for detecting BI-RADS 4 or higher lesions by 25% and improved specificity for BI-RADS 3 lesions by 8%, compared to mammography alone.